Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Targeting colon cancer stem cells might lead to better treatment results.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.